Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001310379-24-000002·SEELOS THERAPEUTICS, INC.
Schedule 13G ownership disclosure
Seelos Therapeutics Inc (US)
Common Stock · CUSIP: 81577F406
Event date: 2024-11-14
- Filing-level shares
- 46,480.00
- Percent of class
- 10.7%
- Weber Mark
Shares: 46,480.00 · Class: 10.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001310379-24-000002
- Form type
- SCHEDULE 13G
- Filer
- SEELOS THERAPEUTICS, INC.
- CIK
- CIK 1017491
- Filed
- Nov 25, 2024
- Reporting period
- Nov 14, 2024
- Description
- Schedule 13G beneficial ownership